CrossrefInfokarte
Restoring Immune Mediated Disease Control by Ipilimumab Re-exposition in a Heavily pretreated Patient With MSI-H mCRC
Clinical Colorectal Cancer · 2022-09 · 21 (3) · e148-e151
DOI: 10.1016/j.clcc.2022.01.003 ↗Abstract
Kein Abstract verfügbar.
EUVIMED